News from the healthcare data industry
Immune checkpoint inhibitors, which strengthen the immune response against tumor cells, have become standard of care for many patients with advanced cancers; however, the medications can often cause side effects,...
– Freenome surpasses $1B in total funding with major investment from Roche – Freenome to expand platform to other cancers with dedicated multicancer and real-world data studies NEWS PROVIDED BYFreenome...
SAN FRANCISCO, Jan. 04, 2022 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced a...
Real-world data from the PACIFIC-R trial (NCT03798535) evaluating durvalumab (Imfinizi) following chemoradiotherapy in patients with stage III, unresectable non–small cell lung cancer (NSCLC) provide evidence supporting the agent’s efficacy in...
December 16, 2021 COTA Team Majority of providers also believe all cancer clinical trials should include real-world data to ensure diverse representation in treatments. COTA announced insights from a study...
CAMBRIDGE, Mass., Dec. 16, 2021 /PRNewswire/ — ConcertAI, LLC (ConcertAI), a leader in enterprise artificial intelligence (AI) Software-as-a-Service (SaaS) and Real-world Evidence (RWE) solutions for life science companies and healthcare providers, announced today...
SAN FRANCISCO and DOVER, Del., Dec. 15, 2021 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care,...
December 11, 2021 09:35 AM Eastern Standard Time BEERSE, Belgium–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new analyses illustrating responses that first-line treatment with DARZALEX®▼ (daratumumab)-based...
Dec 10, 2021 | Turna Ray NEW YORK – An evaluation of real-world BRCA1/2 testing patterns among triple-negative breast cancer patients has shown that African American women within four community health systems...
TAMPA, Fla., Dec. 9, 2021 /PRNewswire/ — M2GEN, a bioinformatics company accelerating discoveries in oncology research through superior data and analytics, today announced it is partnering with Microsoft to advance and scale...